The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Apoptosis and melanoma: molecular mechanisms
Abstract
Melanoma cells can undergo self‐destruction via programmed cell death, i.e. apoptosis. In these tumours, the molecular components of apoptosis include positive (apoptotic) and negative (anti‐apoptotic) regulators. The former include p53, Bid, Noxa, PUMA, Bax, TNF, TRAIL, Fas/FasL, PITSLRE, interferons, and c‐KIT/SCF. The latter include Bcl‐2, Bcl‐X L , Mcl‐1, NF‐ K B, survivin, livin, and ML‐IAP. Alternatively, some molecules such as TRAF‐2, c‐Myc, endothelins, and integrins may have either pro‐ or anti‐apoptotic effects. Some of these molecules are of potential therapeutic use, such as: (1) p53, which influences resistance to chemotherapy; (2) Mcl‐1 and Bcl‐X L , which can override apoptosis; (3) TRAIL, which has selective fatal effects on tumour cells; (4) NF‐ K B, which when downregulated sensitizes cells to TRAIL and TNF; (5) the PITSLRE kinases, whose alteration appears to result in Fas resistance; (6) interferons, which sensitize cells to other factors; and (7) survivin and other IAPs that inhibit apoptosis. This review summarizes the state of current knowledge about the key molecular components and mechanisms of apoptosis in melanoma, discusses potential therapeutic ramifications, and provides directions for future research. Copyright © 2003 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Ambrosini, G., Adida, C., & Altieri, D. C. (1997) · Nature Medicine · doi:10.1038/nm0897-917 · Cited by 3,165
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711
IAP family proteins---suppressors of apoptosis
Deveraux, Q. L., & Reed, J. C. (1999) · Genes & Development · doi:10.1101/gad.13.3.239 · Cited by 2,551
Inoue, A., Yanagisawa, M., Kimura, S., Kasuya, Y., Miyauchi, T., Goto, K., & Masaki, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2863 · Cited by 2,517
Suda, T., Takahashi, T., Golstein, P., & Nagata, S. (1993) · Cell · doi:10.1016/0092-8674(93)90326-l · Cited by 2,489
Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
Sakurai, T., Yanagisawa, M., Takuwat, Y., Miyazakit, H., Kimura, S., Goto, K., & Masaki, T. (1990) · Nature · doi:10.1038/348732a0 · Cited by 2,424
Control of apoptosis and mitotic spindle checkpoint by survivin
Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C., & Altieri, D. C. (1998) · Nature · doi:10.1038/25141 · Cited by 1,870
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
Trauth, B. C., Klas, C., Peters, A. M. J., Matzku, S., Möller, P., Falk, W., Debatin, K.-M., & Krammer, P. H. (1989) · Science · doi:10.1126/science.2787530 · Cited by 1,716
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis
Sakahira, H., Enari, M., & Nagata, S. (1998) · Nature · doi:10.1038/34214 · Cited by 1,656
A Matter of Life and Cell Death
Evan, G., & Littlewood, T. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,523
Yin, X.-M., Oltvai, Z. N., & Korsmeyer, S. J. (1994) · Nature · doi:10.1038/369321a0 · Cited by 1,316
A novel domain within the 55 kd TNF receptor signals cell death
Tartaglia, L. A., Ayres, T. M., Wong, G. H. W., & Goeddel, D. V. (1993) · Cell · doi:10.1016/0092-8674(93)90464-2 · Cited by 1,288
Apoptosis control by death and decoy receptors
Ashkenazi, A., & Dixit, V. M. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80034-9 · Cited by 1,288
MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1
Malinin, N. L., Boldin, M. P., Kovalenko, A. V., & Wallach, D. (1997) · Nature · doi:10.1038/385540a0 · Cited by 1,280
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
Hahne, M., Rimoldi, D., Schröter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., et al. (1996) · Science · doi:10.1126/science.274.5291.1363 · Cited by 1,249
Tamm, I., Wang, Y., Sausville, E. A., Scudiero, D. A., Vigna, N. J., Oltersdorf, T., & Reed, J. C. (1998) · PubMed · Cited by 1,244
Gross, A., Yin, X.-M., Wang, K., Wei, M. C., Jockel, J., Milliman, C., Erdjument-Bromage, H., Tempst, P., & Korsmeyer, S. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.1156 · Cited by 1,045
BH3-Only Proteins—Essential Initiators of Apoptotic Cell Death
Huang, D. C. S., & Strasser, A. (2000) · Cell · doi:10.1016/s0092-8674(00)00187-2 · Cited by 1,043
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) · Nature · doi:10.1038/35051606 · Cited by 966
Apoptotic cell death induced by c-myc is inhibited by bcl-2
Bissonnette, R. P., Echeverri, F., Mahboubi, A., & Green, D. R. (1992) · Nature · doi:10.1038/359552a0 · Cited by 957
Degli-Esposti, M. A., Dougall, W. C., Smolak, P. J., Waugh, J. Y., Smith, C. A., & Goodwin, R. G. (1997) · Immunity · doi:10.1016/s1074-7613(00)80399-4 · Cited by 821
p53: oncogene or anti-oncogene?
Lane, D. P., & Benchimol, S. (1990) · Genes & Development · doi:10.1101/gad.4.1.1 · Cited by 795
Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA
Jacobson, M. D., Burne, J. F., King, M. P., Miyashrta, T., Reed, J. C., & Raff, M. C. (1993) · Nature · doi:10.1038/361365a0 · Cited by 751
TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-κB
Schneider, P., Thome, M., Burns, K., Bodmer, J.-L., Hofmann, K., Kataoka, T., Holler, N., & Tschopp, J. (1997) · Immunity · doi:10.1016/s1074-7613(00)80401-x · Cited by 696
High levels of p53 protein in UV-irradiated normal human skin.
Hall, P. A., Ph, M., Hd, M., Dover, R., & Lane, D. P. (1993) · PubMed · Cited by 673
Intracellular Regulation of TRAIL-Induced Apoptosis in Human Melanoma Cells
Griffith, T. S., Chin, W. A., Jackson, G. C., Lynch, D. H., & Kubin, M. Z. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2833 · Cited by 664
Raisova, M., Hossini, A. M., Eberle, J., Riebeling, C., Orfanos, C. E., Geilen, C. C., Wieder, T., Sturm, I., & Daniel, P. T. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01409.x · Cited by 575
Premature p34 cdc2 Activation Required for Apoptosis
Shi, L., Nishioka, W. K., Th'ng, J., Bradbury, E. M., Litchfield, D. W., & Greenberg, A. H. (1994) · Science · doi:10.1126/science.8108732 · Cited by 557
The Serine Protease Omi/HtrA2 Regulates Apoptosis by Binding XIAP through a Reaper-like Motif
Martins, L. M., Iaccarino, I., Tenev, T., Gschmeissner, S., Totty, N. F., Lemoine, N. R., Savopoulos, J., Gray, C. W., Creasy, C. L., Dingwall, C., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109784200 · Cited by 542
The CARD domain: a new apoptotic signalling motif
Hofmann, K. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01043-8 · Cited by 528
Wyllie, A. H. (1997) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011623 · Cited by 497
Livin, a Novel Inhibitor of Apoptosis Protein Family Member
Kasof, G. M., & Gomes, B. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003670200 · Cited by 454
ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas
Vucic, D., Stennicke, H. R., Pisabarro, M. T., Salvesen, G. S., & Dixit, V. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00781-8 · Cited by 414
Zhang, X. D., Franco, A., Myers, K., Gray, C. P., Nguyen, T., & Hersey, P. (1999) · PubMed · Cited by 385
Molecular determinants of response to TRAIL in killing of normal and cancer cells.
Kim, K., Fisher, M. J., Xu, S., & El‐Deiry, W. S. (2000) · PubMed · Cited by 376
Expression and Targeting of the Apoptosis Inhibitor, Survivin, in Human Melanoma
Grossman, D., McNiff, J. M., Li, F., & Altieri, D. C. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00776.x · Cited by 365
Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back
Walker, P. R., Saas, P., & Dietrich, P. Y. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4521 · Cited by 327
Thomas, W. D., & Hersey, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2195 · Cited by 326
Inhibition of melanoma tumor growth in vivo by survivin targeting
Grossman, D., Kim, P. J., Schechner, J. S., & Altieri, D. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.635 · Cited by 286
Huang, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.15.4358 · Cited by 257
Gottschalk, A. R., Boise, L. H., Thompson, C. B., & Quintáns, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7350 · Cited by 248
Chawla‐Sarkar, M., Leaman, D. W., & Borden, E. C. (2001) · PubMed · Cited by 245
Reynolds, J. E., Yang, T., Lü, Q., Jenkinson, J. D., Zhou, P., Eastman, A. R., & Craig, R. W. (1994) · PubMed · Cited by 240
Zhang, X. D., Nguyen, T., Thomas, W. D., Sanders, J. E., & Hersey, P. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02042-1 · Cited by 218
Natali, P. G., Nicotra, M. R., Winkler, A. B., Cavaliere, R., Bigotti, A., & Ullrich, A. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520207 · Cited by 211
Activation of the SAPK pathway by the human STE20 homologue germinal centre kinase
Pombo, C. M., Kehrl, J. H., Sánchez, I., Katz, P., Avruch, J., Zon, L. I., Woodgett, J. R., Force, T., & Kyriakis, J. M. (1995) · Nature · doi:10.1038/377750a0 · Cited by 210
Apoptosis signaling in lymphocytes
Scaffidi, C., Kirchhofft, S., Krammer, P. H., & Peter, M. E. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80045-4 · Cited by 204
Integrin expression in human melanoma cells with differing invasive and metastatic properties
Gehlsen, K. R., Davis, G. E., & Sriramarao, P. (1992) · Clinical & Experimental Metastasis · doi:10.1007/bf00114587 · Cited by 192
SMAC Negatively Regulates the Anti-apoptotic Activity of Melanoma Inhibitor of Apoptosis (ML-IAP)
Vucic, D., Deshayes, K., Ackerly, H., Pisabarro, M. T., Kadkhodayan, S., Fairbrother, W. J., & Dixit, V. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112045200 · Cited by 162
Reid, K., Turnley, A. M., Maxwell, G. D., Kurihara, Y., Kurihara, H., Bartlett, P. F., & Murphy, M. (1996) · Development · doi:10.1242/dev.122.12.3911 · Cited by 160
Expression of apoptosis regulators in cutaneous malignant melanoma.
Tang, L., Tron, V. A., Reed, J. C., Mah, K., Krajewska, M., Li, G., Xin Min, Z. H. O. U., Ho, V. C., & Trotter, M. J. (1998) · PubMed · Cited by 152
Franco, A. V., Zhang, X. D., Berkel, E. V., Sanders, J. E., Zhang, X. Y., Thomas, W. D., Nguyen, T. T., & Hersey, P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5337 · Cited by 150
Lahav, R., Heffner, G. C., & Patterson, P. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11496 · Cited by 150
Loetscher, H., Gentz, R., Zulauf, M., Lustig, A., Tabuchi, H., Schlaeǵer, E.-J., Brockhaus, M., Gallati, H., Manneberg, M., & Lesslauer, W. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55273-x · Cited by 148
Loss of c-kit expression in cultured melanoma cells.
Lassam, N. J., & Bickford, S. (1992) · PubMed · Cited by 147
Stressed to Death: Regulation of Apoptotic Signaling Pathways by the Heat Shock Proteins
Beere, H. M. (2001) · Science Signaling · doi:10.1126/stke.2001.93.re1 · Cited by 144
Alterations of Fas (Apo-1/CD95) Gene in Cutaneous Malignant Melanoma
Shin, M. S., Park, W. S., Kim, S., Kim, H. S., Kang, S. J., Song, K. Y., Park, J. Y., Dong, S. M., Pi, J. H., Oh, R. R., et al. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65434-x · Cited by 137
Selzer, E., Schlagbauer‐Wadl, H., Okamoto, I., Pehamberger, H., P�tter, R., & Jansen, B. (1998) · Melanoma Research · doi:10.1097/00008390-199806000-00001 · Cited by 134
Ivanov, V. N., & Ronai, Z. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203602 · Cited by 130
Yamada, H., Tada‐Oikawa, S., Uchida, A., & Kawanishi, S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1641 · Cited by 124
Leonetti, C., D’Agnano, I., Lozupone, F., Valentini, A., Geiser, T., Zon, G., Calabretta, B., Citro, G., & Zupi, G. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.7.419 · Cited by 121
BAX and BH3-domain-only proteins in p53-mediated apoptosis
Wu, X., & Deng, Y. (2002) · Frontiers in bioscience · doi:10.2741/a772 · Cited by 118
EDITORIAL. p53—INTEGRATING THE COMPLEXITY
Hall, P. A., Meek, D. W., & Lane, D. P. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199609)180:1<1::aid-path712>3.0.co;2-u · Cited by 113
Thomas, W. D., Zhang, X. D., Franco, A. V., Nguyen, T. T., & Hersey, P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5612 · Cited by 110
Endothelin-induced Apoptosis of A375 Human Melanoma Cells
Okazawa, M., Shiraki, T., Ninomiya, H., Kobayashi, S., & Masaki, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12584 · Cited by 107
KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells.
Zakut, R., Perlis, R. H., Eliyahu, S., Yarden, Y., Givol, D., Lyman, S. D., & Halaban, R. (1993) · PubMed · Cited by 104
Leonetti, C., Biroccio, A., Candiloro, A., Citro, G., Fornari, C., Mottolese, M., Bufalo, D. D., & Zupi, G. (1999) · PubMed · Cited by 101
Raisova, M., Bektas, M., Wieder, T., Daniel, P. T., Eberle, J., Orfanos, C. E., & Geilen, C. C. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01491-5 · Cited by 96
A labile repressor acts through the NFkB-like binding sites of the human urokinase gene
Novak, U., Cocks, B. G., & Hamilton, J. A. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.12.3389 · Cited by 94
p53 gene mutation and expression in naevi and melanomas
Sparrow, L. E., Soong, R., Dawkins, H. J. S., Iacopetta, B. J., & Heenan, P. J. (1995) · Melanoma Research · doi:10.1097/00008390-199504000-00004 · Cited by 84
Kimura, S., Maekawa, T., Hirakawa, K., Murakami, A., & Abé, T. (1995) · PubMed · Cited by 84
Biroccio, A., Benassi, B., Amodei, S., Gabellini, C., Bufalo, D. D., & Zupi, G. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.174 · Cited by 79
Nitric oxide-mediated apoptosis of K-1735 melanoma cells is associated with downregulation of Bcl-2
Xie, K., Wang, Y., Huang, S., Xu, L., Bielenberg, D. R., Salas, T. R., McConkey, D. J., Jiang, W., & Fidler, I. J. (1997) · Oncogene · doi:10.1038/sj.onc.1201239 · Cited by 77
Jones, P. A. (2001) · Nature · doi:10.1038/35051677 · Cited by 71
Henry, H., Thomas, A. E., Shen, Y., & White, E. (2002) · Oncogene · doi:10.1038/sj.onc.1205125 · Cited by 69
Weber, C. H., & Vincenz, C. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02162-7 · Cited by 67
Ariza, M. E., Broome-Powell, M., Lahti, J. M., Kidd, V. J., & Nelson, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28505 · Cited by 67
Ugurel, S., Seiter, S., Rappl, G., Stark, A., Tilgen, W., & Reinhold, U. (1999) · International Journal of Cancer · Cited by 61
Translocation of TRAF Proteins Regulates Apoptotic Threshold of Cells
Arch, R. H., Gedrich, R. W., & Thompson, C. B. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2873 · Cited by 59
Kim, S., Ravi, G., Hoffmann, C., Jung, Y.-J., Kim, M., Chen, A., & Jacobson, K. A. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00839-0 · Cited by 58
Lack ofp53 mutations and loss of heterozygosity in non-cultured human melanocytic lesions
Papp, T., Jafari, M., & Schiffmann, D. (1996) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01213550 · Cited by 57
Bakker, T. R., Reed, D. S., Renno, T., & Jongeneel, C. V. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990118)80:2<320::aid-ijc24>3.0.co;2-k · Cited by 57
Nelson, M. A., Ariza, M. E., Yang, J., Thompson, F. H., Taetle, R., Trent, J. M., Wymer, J. A., Massey, K., Broome-Powell, M., Easton, J. B., et al. (1999) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(98)00122-8 · Cited by 55
Eberle, J., Weitmann, S., Thieck, O., Pech, H., Orfanos, C. E., & Paul, M. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00598.x · Cited by 55
Zhang, X., Xu, Q., & Saiki, I. (2000) · Clinical & Experimental Metastasis · doi:10.1023/a:1010960615370 · Cited by 53
Human melanoma cell line UV responses show independency of p53 function.
Haapajärvi, T., Pitkänen, K., & Laiho, M. (1999) · PubMed · Cited by 53
Öğretmen, B., & Safa, A. R. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960904)67:5<608::aid-ijc3>3.0.co;2-y · Cited by 52
Myc down-regulation induces apoptosis in M14 melanoma cells by increasing p27kip1 levels
D’Agnano, I., Valentini, A., Fornari, C., Bucci, B., Starace, G., Felsani, A., & Citro, G. (2001) · Oncogene · doi:10.1038/sj.onc.1204392 · Cited by 48
bcl-2 Expression in Melanocytic Nevi
Morales-Ducret, C. R. (1995) · Archives of Dermatology · doi:10.1001/archderm.131.8.915 · Cited by 47
p53 Protein Detected By Immunohistochemical Staining is Not Always Mutant
MacGeoch, C., Barnes, D. M., Newton, J. A., Mohammed, S. N., Hodgson, S. V., Ng, M. H., Bishop, D. T., & Spurr, N. K. (1993) · Disease Markers · doi:10.1155/1993/480686 · Cited by 45
Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type
Akslen, L. A., Monstad, S. E., Larsen, B., Straume, O., & Øgreid, D. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980220)79:1<91::aid-ijc17>3.0.co;2-k · Cited by 45
Role of TRAF2/GCK in melanoma sensitivity to UV-induced apoptosis
Ivanov, V. N., Kehrl, J. H., & Ronai, Z. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203415 · Cited by 38
bcl-2 Expression in Melanocytic Nevi
Morales-Ducret, C. R. (1995) · Archives of Dermatology · doi:10.1001/archderm.1995.01690200051010 · Cited by 29
Mecchia, M., Matarrese, P., Malorni, W., D’Agostino, G., Sestili, P., Santini, S. M., Gauzzi, M. C., Venditti, M., Mazzocchi, A., Parmiani, G., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301059 · Cited by 28
Inhibition of Growth of Melanoma Cells by CD95 (Fas/APO-1) Gene Transfer In Vivo
Aragane, Y., Maeda, A., Cui, C., Tezuka, T., Kaneda, Y., & Schwarz, T. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00164.x · Cited by 23
Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation
(1993) · Lung Cancer · doi:10.1016/0169-5002(93)90516-z · Cited by 2
Cited by
Anticancer therapy targeting the apoptotic pathway
Hu, W., & Kavanagh, J. J. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01277-4 · Cited by 510
Apoptosis in the ovary: molecular mechanisms
Hussein, M. R. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi001 · Cited by 502
Self-citationFelicetti, F., Errico, M. C., Bottero, L., Segnalini, P., Stoppacciaro, A., Biffoni, M., Felli, N., Mattia, G., Petrini, M., Colombo, M. P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2538 · Cited by 377
Ultraviolet radiation and skin cancer: molecular mechanisms
Hussein, M. R. (2005) · Journal of Cutaneous Pathology · doi:10.1111/j.0303-6987.2005.00281.x · Cited by 352
Self-citationThe inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer
NACHMIAS, B., ASHHAB, Y., & BENYEHUDA, D. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.04.002 · Cited by 266
Metadata
- Authors
- Hussein, M. R., Haemel, A. K., & Wood, G. S.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2003-01-13
- Volume
- 199
- Issue
- 3
- Pages
- 275-288
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W1974421438
- Cited by
- 272
- References
- 100
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.